PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONThe registrant lobbying for itself | 2026-Q2: $3,282,990 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- ANTHONY BUSH · 1 report
- DAVID MARIN · 1 report
- EMILY THREADGILL · 1 report
- JONATHAN M HEAFITZ · 1 report
- LUCIA LEBENS · 1 report
Bills named, and how the House and the Senate voted
40 bills named in these reports. 1 of them became law, and our record holds how the House and the Senate voted on it. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 7148Consolidated Appropriations Act, 2026 | Became law | Public Law 119-75House 217–214 · Senate 71–29 |
| H.R. 1244Reducing Drug Prices for Seniors Act | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 3164Ensuring Community Access to Pharmacist Services Act | Introduced | No recorded vote in our record |
| H.R. 4317PBM Reform Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 4409Fair Pharmacies for Federal Employees Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 4570Interagency Patent Coordination and Improvement Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 5582Patients Deserve Price Tags Act | Introduced | No recorded vote in our record |
| H.R. 6609Pharmacists Fight Back in Medicare and Medicaid Act | Introduced | No recorded vote in our record |
| H.R. 6610Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] | Introduced | No recorded vote in our record |
| H.R. 6837To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. | Introduced | No recorded vote in our record |
| H.R. 7871MVP Act | Introduced | No recorded vote in our record |
| H.R. 7895PBM Kickback Prohibition Act | Reported by committee | No recorded vote in our record |
| H.R. 8143Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026. | Introduced | No recorded vote in our record |
| H.R. 8324Great American Healthcare Plan | Introduced | No recorded vote in our record |
| H.R. 8779PBM Act | Introduced | No recorded vote in our record |
| H.R. 9117CHECK Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9228Health DATA Act of 2026 | Reported by committee | No recorded vote in our record |
| H.R. 9393Lower Costs, More Transparency Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9486Health DATA Act of 2026 | Introduced | No recorded vote in our record |
| S. 526Pharmacy Benefit Manager Transparency Act of 2025 | Introduced | No recorded vote in our record |
| S. 882Patients Before Middlemen Act | Introduced | No recorded vote in our record |
| S. 927Protecting Pharmacies in Medicaid Act | Introduced | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 1095Stop STALLING Act | Reported by committee | No recorded vote in our record |
| S. 1096Preserve Access to Affordable Generics and Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1097Interagency Patent Coordination and Improvement Act of 2025 | Reported by committee | No recorded vote in our record |
| S. 1414Expedited Access to Biosimilars Act | Reported by committee | No recorded vote in our record |
| S. 1637MVP Act | Introduced | No recorded vote in our record |
| S. 2355Patients Deserve Price Tags Act | Reported by committee | No recorded vote in our record |
| S. 2426Equitable Community Access to Pharmacist Services Act | Introduced | No recorded vote in our record |
| S. 2617Reducing Drug Prices for Seniors Act. | Introduced | No recorded vote in our record |
| S. 2800Pharmacy and Medically Underserved Areas Enhancement Act | Introduced | No recorded vote in our record |
| S. 3345PBM Price Transparency and Accountability Act | Introduced | No recorded vote in our record |
| S. 3349PBM Disclosure Act | Introduced | No recorded vote in our record |
| S. 3549PBM FAIR Act | Introduced | No recorded vote in our record |
| S. 3822Break Up Big Medicine Act | Introduced | No recorded vote in our record |
| S. 4189INSULIN Act of 2026 | Reported by committee | No recorded vote in our record |
| S. 4323Ensuring Access to Lower-Cost Medicines for Seniors Act | Introduced | No recorded vote in our record |
| S. 4509PBM Act | Introduced | No recorded vote in our record |
Issues named: Health Issues (1), Medicare/Medicaid (1), Pharmacy (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPharmacy, Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Eugene Simon Vindman DDemocrat | VINDMAN FOR CONGRESSFrom PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION POLITICAL ACTION COMMITTEE (PCMA PAC) | $500 | The report on LDA.gov | |
| Josh Gottheimer DDemocrat | JOSH FOR JERSEYFrom PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION POLITICAL ACTION COMMITTEE (PCMA PAC) | $500 | The report on LDA.gov | |
| Angie Craig DDemocrat | ANGIE CRAIG FOR CONGRESSFrom PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION POLITICAL ACTION COMMITTEE (PCMA PAC) | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION POLITICAL ACTION COMMITTEE (PCMA PAC) | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.